- Organizations: Lilly
Pipeline
Lilly gains exclusive global rights to MeiraGTx's ophthalmic genetic therapies
Strategic partnership extends to MeiraGTx’s investigational genetic medicine for LCA4-AIPLI-associated congenital blindness among pediatric patients.Business